Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.2.3.21EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.2.3.21ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.3.21ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JG.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JG.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JG.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JG.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JG.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
JM.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
JM.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JM.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
JM.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JM.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JM.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JM.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JM.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.22.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.22.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.22.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.22.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.22.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.22.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.22.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.22.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GS.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GS.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GS.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GS.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GS.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GS.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GS.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GS.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.24EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HK.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.24ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HK.24ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HK.24EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HK.24EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HK.24ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.24ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XCFEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XCFEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCFECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XCFECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XCFEHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GJ.5.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GJ.5.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GJ.5.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GJ.5.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GJ.5.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used